Evidence map›Paper›PMID 40118791›Full record

Observational studyJournal of the American Heart Association2025

Alterations in Liver Perfusion in Adults With Fontan Circulation as Assessed by Dual Cholate Clearance.

Yuli Y Kim, Annique Nyman, Yuan-Shung Huang, Alexis Z Tomlinson, Michael P McRae, Greg T Everson, Sumeet Vaikunth, Benjamin Rosenthal, Jack Rychik, Maarouf A Hoteit

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03726229 (Development of a Reliable Means for Functional Assessment of Liver Performance After the Fontan Operation), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03726229 completednot on this map

Development of a Reliable Means for Functional Assessment of Liver Performance After the Fontan Operation: Dual Cholate Clearance Assay

TypeobservationalSponsorUniversity of PennsylvaniaRan2019 to 2022Enrolled50ConditionsFontan ProcedureArmsCholate assay
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuli Y KimDivision of Cardiology Hospital of the University of Pennsylvania Philadelphia PA.ORCID 0000-0002-2342-192X
Annique NymanDivision of Cardiology Children's Hospital of Philadelphia Philadelphia PA.
Yuan-Shung HuangData Science and Biostatistics Unit, Department of Biomedical and Health Informatics Children's Hospital of Philadelphia Philadelphia PA.ORCID 0000-0002-1942-6197
Alexis Z TomlinsonData Science and Biostatistics Unit, Department of Biomedical and Health Informatics Children's Hospital of Philadelphia Philadelphia PA.ORCID 0000-0003-1681-0457
Michael P McRaeHepQuant LLC Denver CO.ORCID 0000-0002-2126-9442
Greg T EversonHepQuant LLC Denver CO.ORCID 0000-0003-0454-3566
Sumeet VaikunthDivision of Cardiology Hospital of the University of Pennsylvania Philadelphia PA.ORCID 0000-0001-5891-3548
Benjamin RosenthalDivision of Hepatology Hospital of the University of Pennsylvania Philadelphia PA.ORCID 0000-0001-6357-9097
Jack RychikDivision of Cardiology Children's Hospital of Philadelphia Philadelphia PA.
Maarouf A HoteitDivision of Hepatology Hospital of the University of Pennsylvania Philadelphia PA.ORCID 0000-0001-6053-6884

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFontan circulation (FC) in complex congenital heart disease is characterized by altered hemodynamics and associated with Fontan-associated liver disease. Patients with FC may exhibit abnormalities in cholate clearance due to abnormal perfusion. We aimed to compare cholate clearance in adults with FC to healthy controls and explore associations between cholate clearance and clinical features. METHODS AND

resultsThis is a prospective cohort study of patients with FC ≥18 years of age between 2019 and 2022. Systemic and portal hepatic clearance of cholate was assessed using a dual cholate clearance assay (HepQuant Shunt), measuring systemic and portal hepatic filtration rates (HFRs). Systemic HFR/portal HFR ratio (SHUNT%) was calculated. Participants with FC and healthy controls were compared using the Fisher exact test and Wilcoxon test. Univariable regression and multivariable analyses determined associations with clinical variables. There were 35 participants with FC (54% women; median age 29.0 years [interquartile range, 24.0-36.0], 91% White) and 26 controls. In addition to lower platelet counts and higher aspartate aminotransferase to platelet ratio index, and Fibrosis-4 indices, FC participants had lower systemic HFR and portal HFR. SHUNT% was comparable with controls but ranged from 8% to 76%, with 8 (23%) having SHUNT% >30%. In those with FC, increase in SHUNT% was associated with elevated Fontan pressure, higher aortopulmonary collateral flow, decreased oxygen saturation, elevated NT-proBNP (N-terminal pro-B-type natriuretic peptide) levels, thrombocytopenia, and Fibrosis-4 ≥1.45.

conclusionsCholate clearance, as defined by systemic and portal HFR, is impaired in those with FC. Features of worse Fontan physiology correlate with higher SHUNT%, supporting the hypothesis that hemodynamic derangements play a role in progression of Fontan-associated liver disease. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03726229.

Indexed as

Fontan ProcedureHeart Defects, CongenitalLiverLiver CirculationLiver DiseasesAdultCase-Control StudiesFemaleHemodynamicsHumansMaleProspective StudiesYoung Adultcongenital heart diseaseFontanFontan‐associated liver diseasesingle ventricle

Identifiers

PMID40118791
PMCPMC12132848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.